Publications 2003
Atkinson, B. T., Ellmeier, W. & Watson, S. P. Tec regulates platelet activation by GPVI in the absence of Btk. Blood 102, 3592-3599, doi:10.1182/blood-2003-04-1142 (2003).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/12842985
Lehner, M., Stockl, J., Majdic, O., Knapp, W., Huttner, K., Felzmann, T. & Holter, W. MHC class II antigen signaling induces homotypic and heterotypic cluster formation of human mature monocyte derived dendritic cells in the absence of cell death. Hum Immunol 64, 762-770, doi:10.1016/s0198-8859(03)00094-6 (2003).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/12878354
Saemann, M. D., Diakos, C., Kelemen, P., Kriehuber, E., Zeyda, M., Bohmig, G. A., Horl, W. H., Baumruker, T. & Zlabinger, G. J. Prevention of CD40-triggered dendritic cell maturation and induction of T-cell hyporeactivity by targeting of Janus kinase 3. Am J Transplant 3, 1341-1349, doi:10.1046/j.1600-6143.2003.00225.x (2003).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/14525593
Saemann, M. D., Zeyda, M., Diakos, C., Szekeres, A., Bohmig, G. A., Kelemen, P., Parolini, O., Stockinger, H., Prieschl, E. E., Stulnig, T. M., Baumruker, T. & Zlabinger, G. J. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154. Transplantation 75, 1864-1872, doi:10.1097/01.TP.0000065738.58742.A9 (2003).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/12811247
Saemann, M. D. & Zlabinger, G. J. How to make clinical use of bacterial evasion strategies. Eur J Clin Invest 33, 189-190, doi:10.1046/j.1365-2362.2003.01145.x (2003).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/12641535
Selenko-Gebauer, N., Majdic, O., Szekeres, A., Hofler, G., Guthann, E., Korthauer, U., Zlabinger, G., Steinberger, P., Pickl, W. F., Stockinger, H., Knapp, W. & Stockl, J. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J Immunol 170, 3637-3644, doi:10.4049/jimmunol.170.7.3637 (2003).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/12646628
Staffler, G., Szekeres, A., Schutz, G. J., Saemann, M. D., Prager, E., Zeyda, M., Drbal, K., Zlabinger, G. J., Stulnig, T. M. & Stockinger, H. Selective inhibition of T cell activation via CD147 through novel modulation of lipid rafts. J Immunol 171, 1707-1714, doi:10.4049/jimmunol.171.4.1707 (2003).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/12902469
Stollberger, C., Finsterer, J., Zlabinger, G. J., Weihsengruber, F., Redtenbacher, S., Bonner, G., Herkner, K. & Deutsch, M. Antineutrophil cytoplasmic autoantibody-negative antiproteinase 3 syndrome presenting as vasculitis, endocarditis, polyneuropathy and Dupuytren's contracture. J Heart Valve Dis 12, 530-534 (2003).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/12918859
Wahrmann, M., Exner, M., Regele, H., Derfler, K., Kormoczi, G. F., Lhotta, K., Zlabinger, G. J. & Bohmig, G. A. Flow cytometry based detection of HLA alloantibody mediated classical complement activation. J Immunol Methods 275, 149-160, doi:10.1016/s0022-1759(03)00012-7 (2003).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/12667679
Zeyda, M., Szekeres, A. B., Saemann, M. D., Geyeregger, R., Stockinger, H., Zlabinger, G. J., Waldhausl, W. & Stulnig, T. M. Suppression of T cell signaling by polyunsaturated fatty acids: selectivity in inhibition of mitogen-activated protein kinase and nuclear factor activation. J Immunol 170, 6033-6039, doi:10.4049/jimmunol.170.12.6033 (2003).
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/12794131
